Founders Capital Management Nkarta, Inc. Transaction History
Founders Capital Management
- $154 Million
- Q1 2025
A detailed history of Founders Capital Management transactions in Nkarta, Inc. stock. As of the latest transaction made, Founders Capital Management holds 5,000 shares of NKTX stock, worth $8,500. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,000
Previous 1,000
400.0%
Holding current value
$8,500
Previous $2,000
400.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NKTX
# of Institutions
121Shares Held
61.1MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$18.4 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$6.9 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$6.41 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.07 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$6.06 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $82.7M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...